Veon (VEON) Cash & Equivalents (2009 - 2026)

Veon has reported Cash & Equivalents for 18 years, with the latest figure at $1.8 billion in Q1 2026.

• For the quarter ending Q1 2026, Cash & Equivalents fell 1.24% year-over-year to $1.8 billion; the trailing twelve-month figure through Mar 2026 stood at $1.8 billion (down 1.24% YoY), and the FY2025 full-year result was $1.7 billion, up 2.55% from the prior year.
• Cash & Equivalents for Q1 2026 stood at $1.8 billion, up from $1.7 billion in the prior quarter.
• The five-year high for Cash & Equivalents was $2.5 billion in Q2 2023, with the low at $4.0 million in Q4 2023.
• Historically, Cash & Equivalents has averaged $1.4 billion across 5 years, with a median of $1.7 billion in 2024.
• Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 88.89% — and 2024, when it surged 42125.0%.
• Veon's Cash & Equivalents stood at $6.0 million in 2022, then plunged by 33.33% to $4.0 million in 2023, then surged by 42125.0% to $1.7 billion in 2024, then advanced by 2.55% to $1.7 billion in 2025, then climbed by 1.1% to $1.8 billion in 2026.
• The last three Cash & Equivalents figures came in at $1.8 billion (Q1 2026), $1.7 billion (Q4 2025), and $1.3 billion (Q2 2025), per Business Quant data.